Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05809323 · ClinicalTrials.gov registry record · NA
Marfan Syndrome Moderate Exercise Trial II
A NA study of Marfan Syndrome, sponsored by Baylor College of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05809323 is a NA study of Marfan Syndrome that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 50 participants, below the 390-participant average among 4 other Marfan Syndrome trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05809323, a NA study of Marfan Syndrome, is actively recruiting participants, sponsored by Baylor College of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Marfan syndrome (MFS) is a distinctive connective tissue disorder that affects multiple organ systems including the heart, bones, ligaments, and eyes, and is associated with significant risk of aortic dissection. Given limited evidence from in-vitro studies, and theoretical concerns, the majority of patients with MFS are restricted from certain physical activities. The lack of exercise and deconditioning have detrimental effects including increasing weakness, joint pain, decreased endurance, and depressive symptoms. Given the significant paucity of data currently existing on the effects of exercise in humans with MFS, and the recent, optimistic findings in rodent models, this pilot trial was established to assess the effects of moderated dynamic exercise in adolescents and young adults with MFS.
Conditions Studied
Interventions
- OTHER Control Group
- OTHER Exercise Intervention Group
Study Locations (1)
Texas
- Texas Children's Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2027-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05809323
The ClinicalTrials.gov registry entry for NCT05809323 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 390-participant average among 4 other Marfan Syndrome trials with a reported enrollment target (87% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Marfan Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Control Group is the first listed.
NCT05809323 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05809323 about?
NCT05809323 is a clinical study titled "Marfan Syndrome Moderate Exercise Trial II". Marfan syndrome (MFS) is a distinctive connective tissue disorder that affects multiple organ systems including the heart, bones, ligaments, and eyes, and is associated with significant risk of aortic dissection. Given limited evidence from in-vitro studies, and theoretical concerns, the majority of...
What is the current status of trial NCT05809323?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-09-01. Estimated completion is 2027-07-01.
What conditions does trial NCT05809323 study?
This clinical trial studies the following conditions: Marfan Syndrome.
What interventions are being tested in trial NCT05809323?
The interventions under investigation include: Control Group (OTHER), Exercise Intervention Group (OTHER).
Who is sponsoring clinical trial NCT05809323?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05809323 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Marfan Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices
RECRUITING · NA
-
Study of Heritable Connective Tissue Disorders
COMPLETED
-
Effects of Losartan Versus Atenolol on Aortic and Cardiac Muscle Stiffness in Adults With Marfan Syndrome
COMPLETED · Phase 3
-
Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.